FIP is a fatal disease in cats with no chance of natural recovery.

Cats diagnosed with FIP typically reach a critical condition within a week due to the disease's rapid progression, and without treatment, it is invariably fatal. The cost of a full GS-441524 treatment course in the United States is high, excluding veterinary fees.However, molnupiravir EIDD-1931 offers a more effective and affordable solution for this devastating condition. This treatment is 4.4x more effective than EIDD-2801 and 7.3x more effective than GS-441524, ensuring rapid recovery with significant improvement seen within a week. It also has lower cytotoxicity, making it safer for prolonged use, and boasts a near-zero relapse rate, providing lasting peace of mind.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7114919/#:~:text=FIP%20is%20a%20fatal%20immune,found%20in%20cats%20%5B4%5D.

Yes, EIDD-1931 has been used as cure and proven to be highly effective in treating FIP through various university and independent clinical studies. In these studies EIDD-1931 has demonstrated 4.4x higher efficacy than Molnupiravir (EIDD-2801) and 7.3x higher efficacy than GS-441524. In these clinical trials cats demonstrated significant recovery within a week of treatment, with a near-zero relapse rate and less side effects than Molnupiravir (EIDD-2801), making it a safe and reliable treatment option for feline infectious peritonitis. Link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227765/

According to the clinical study published on the National Institutes of Health (USA), 46.2% of cats exhibit clinical signs of improvement within the first week, 84.6% within two weeks, and 92% by the third week. This is a good representation of real world treatment results. Link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612227/

Yes, EIDD-1931 medication is conveniently encapsulated in soft gel capsules . Simply place the capsule behind your cat's tongue or mix it with cat food for easy administration.

MolnuFIP™ EIDD-1931 is most effective for early to mid-stage FIP. EIDD-1931 is especially effective for Wet Form of feline infectious peritonitis. Cats with digestive problems, or are in late stages of infection, exhibiting neurological and ocular symptoms, should start FIP treatment with GS-441524 injections. You can purchase GS-441524 from reputable vendors such as CUREFIP.COM (globally) or BASMIFIP.COM (only in SE Asia). You can transition to EIDD-1931 once your cat's condition stabilises.

No, EIDD-1931 treatment is recommended for a maximum of 60 days. Generally recommended treatment regiment begins with a 30 day treatment. If symptoms persist, continue with another 30 days of treatment. Consult your veterinarian if symptoms persist after 60 days of treatment and switch to GS-441524 injectable or oral treatment solutions.

One capsule every 12 hours, for every 2.5 kg of body weight. Capsules can be administer either on an empty stomach or with meal. If vomiting occurs within 30 minutes, administer another dosage.

Pharmaceutical drug EIDD-2801, commercially known as Molnupiravir is a prodrug commonly used to treat COVID-19 in humans. Upon ingestion by humans or animals, EIDD-2801 is converted by the body into its active form, EIDD-1931.

Clinical researches conducted in the USA and China have shown that EIDD-1931 offered by Molnufip.com is 4.4 times more potent than EIDD-2801 and does not require the body to make the conversion. Additionally, EIDD-1931 exhibits 33% lower cytotoxicity in in vitro tests. Cytotoxicity often leads to undesired and sometimes hard to manage side effects. These findings suggest that EIDD-1931 is a safer and more effective option for treating FIP than Molnupiravir due to its higher potency and lower cytotoxicity.

Yes, it is the most cost effective treatment against FIP available today. A 30 days treatment course starts from $39, which is approximately 10x cheaper than alternative FIP treatments GS-441524.

On average, cats under EIDD-1931 treatment experience 97% success rate in treatment by adhering to our prescribed treatment protocol of 1 capsule every 12 hours for every 2.5kg of body weight. Consult your veterinarian before deviating from our recommended treatment protocol.

EIDD-1931 treatment is not suitable for all FIP infections. Cats exhibiting ocular or neurological symptoms, are in critical conditions, lacking appetite, or have pre-existing liver and kidney conditions should start with 2-4 weeks of GS-441524 injections, or until these conditions are resolved before using EIDD-1931. To purchase GS-441524 visit: https://www.curefip.com

Molnupiravir EIDD-1931 is not recommended for:

• cats with neurological or ocular FIP symptoms.

• cats with digestive problems.

• cats in critical conditions.

• cats with preexisting liver or kidney conditions.

• when treatments exceed 60 days.

Avoid the following medications:

• CYP Enzyme Inhibitors:

  • Certain antifungals (e.g., ketoconazole)

  • Antibiotics (e.g., erythromycin)

  • Other medications (e.g., ritonavir)

• CYP Enzyme Inducers:

  • Rifampin

  • Certain antiepileptics (e.g., phenytoin)

• Medications Affecting Renal Excretion:

  • NSAIDs

  • Certain diuretics

  • Some antibiotics (e.g., aminoglycosides)

• Drugs That Prolong the QT Interval:

  • Certain antipsychotics

  • Antiarrhythmics

  • Antibiotics like macrolides and fluoroquinolones

• Other Antiviral Drugs:

  • Careful evaluation is needed to avoid antagonistic effects or increased toxicity.